Trial Outcomes & Findings for The Hospice Advanced Dementia Symptom Management and Quality of Life Trial (NCT NCT03681119)

NCT ID: NCT03681119

Last Updated: 2020-08-13

Results Overview

Percentage of Hospice IDT Members who Complete Required Education and Training

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

83 participants

Primary outcome timeframe

2 Months

Results posted on

2020-08-13

Participant Flow

Participant milestones

Participant milestones
Measure
Hospice IDT Members
Hospice Interdisciplinary Team (IDT)
Advanced Demential Patients
Dementia symptom management at home hospice edition: quality assurance performance improvement program
Overall Study
STARTED
72
11
Overall Study
COMPLETED
66
11
Overall Study
NOT COMPLETED
6
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Hospice IDT Members
Hospice Interdisciplinary Team (IDT)
Advanced Demential Patients
Dementia symptom management at home hospice edition: quality assurance performance improvement program
Overall Study
No specific reason
4
0
Overall Study
Sickness
2
0

Baseline Characteristics

The Hospice Advanced Dementia Symptom Management and Quality of Life Trial

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Hospice IDT MembersHospice Clinicians (RNs, Social Workers, Ch
n=72 Participants
Hospice Clinicians (RNs, Social Workers, Chaplains) who are given training
Advanced Demential Patients
n=11 Participants
Dementia symptom management at home hospice edition: quality assurance performance improvement program
Total
n=83 Participants
Total of all reporting groups
Age, Continuous
50.7 years
n=99 Participants
86 years
n=107 Participants
68.4 years
n=206 Participants
Sex/Gender, Customized
Sex · Female
57 Participants
n=99 Participants
11 Participants
n=107 Participants
68 Participants
n=206 Participants
Sex/Gender, Customized
Sex · Male
9 Participants
n=99 Participants
0 Participants
n=107 Participants
9 Participants
n=206 Participants
Sex/Gender, Customized
Sex · Unknown or not reported
6 Participants
n=99 Participants
0 Participants
n=107 Participants
6 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
n=99 Participants
0 Participants
n=107 Participants
5 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
67 Participants
n=99 Participants
11 Participants
n=107 Participants
78 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Asian
6 Participants
n=99 Participants
1 Participants
n=107 Participants
7 Participants
n=206 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
n=99 Participants
0 Participants
n=107 Participants
1 Participants
n=206 Participants
Race (NIH/OMB)
Black or African American
19 Participants
n=99 Participants
0 Participants
n=107 Participants
19 Participants
n=206 Participants
Race (NIH/OMB)
White
23 Participants
n=99 Participants
10 Participants
n=107 Participants
33 Participants
n=206 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=99 Participants
0 Participants
n=107 Participants
1 Participants
n=206 Participants
Race (NIH/OMB)
Unknown or Not Reported
22 Participants
n=99 Participants
0 Participants
n=107 Participants
22 Participants
n=206 Participants

PRIMARY outcome

Timeframe: 2 Months

Percentage of Hospice IDT Members who Complete Required Education and Training

Outcome measures

Outcome measures
Measure
Hospice IDT Members
n=72 Participants
Hospice Clinicians (RNs, Social Workers, Chaplains) who are given training
Percentage of Hospice IDT Members Who Complete Required Education and Training
92 percentage of participants

Adverse Events

Advanced Demential Patients

Serious events: 5 serious events
Other events: 0 other events
Deaths: 5 deaths

Serious adverse events

Serious adverse events
Measure
Advanced Demential Patients
n=11 participants at risk
Dementia symptom management at home hospice edition: quality assurance performance improvement program
Nervous system disorders
Death
45.5%
5/11 • Number of events 5 • 1 month
All qualifying adverse events were pulled from all eligible patients' electronic health records. Adverse events were only reported on the Advanced Dementia Patients arm.

Other adverse events

Adverse event data not reported

Additional Information

Abraham Brody, PhD, RN, FAAN

NYU Langone Health

Phone: 212-992-7341

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place